Injectable weight loss  treatments

Wegovy and Mounjaro are both effective for weight loss.  clinical studies have shown that people can lose up to 22.5% of their weight with Mounjaro, and up to 15% of their weight with Wegovy. The active ingredients are slightly different and you may find that one treatment is better for you or that one causes fewer side effects, book a face to face consultation with our Doctor to discuss which medication would be most suitable for you.

 Mounjaro  and Wegovy are both injections for weight loss that have been approved and licensed in the UK for medical professionals only. Wegovy  was the first  to become available ( also known as Ozempic) ,  prior to being prescribed either of the medications you would need a face to face consultation with our Doctor , your medical history will be taken, your eating habits discussed and you will receive  recommendations and dietry advice from our Doctor and advice on  which medication would be most suitable for you will be   based on your medical history, current medications, and body mass index (BMI). to be able to prescribe either of the injectable medications   you will need to  have a BMI of:    30 kg/m2 or more (obese)    27 kg/m2 or more (overweight) and you also have a weight-related medical condition, such as PCOS, sleep apneoa,  prediabetes or high blood pressure

facial treatment

Mounjaro  ( tirzepatide:

The active ingredient in Mounjaro is called tirzepatide.
it  works on two different hormonal receptors: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). You may have heard of GLP-1 from other weight loss injections such as Wegovy.

GLP-1 helps to regulate blood sugar levels,  this in turn talks to the brain to make you feel less hungry and prevent cravings and the feeling to pick at food. It also slows down the emptying of the stomach to keep you feeling fuller for longer making you feel like eating less

GIP regulates energy balance in brain and fat cells, enhancing the GLP-1 effect of suppressing your appetite and improving sugar control.

By mimicking the effects of both these naturally occurring hormones, Mounjaro has been shown to have greater weight loss potential than medicines that work on GLP-1 alone.

Mounjaro starts at £169.00 for 4 weeks treatment ,  this price includes a consultation with our Doctor
in the event you decide not to proceed with the treatment or the Dr advises you that the treatment is not suitable for you  there is no charge.

Mounjaro can cause some side effects to occur. 

Very common ones are gastrointestinal in nature: nausea, vomiting, diarrhoea and constipation. These are mainly seen with dose increases, can be controlled with diet , and tend to settle with time.


information medically reviewed by Dr A. T.  Sharif

 

glowing face

Wegovy  ( Semaglutide)

Wegovy, a brand name for semaglutide, belongs to a group of drugs called GLP-1 agonists - these can also be called GLP-1 analogues, GLP-1 RAs and incretin mimetics.  

Wegovy is designed to reduce appetite, so you eat less. It mimics the action of a gut hormone called GLP-1, which is released after eating, and it slows down how quickly food is digested. This means it can help you stay full for longer, which can lead to weight loss.
   Wegovy  starts at £159.00 for 4 weeks treatment     
this price includes the consultation with our Doctor. in the event you decide not to proceed with the treatment or the Dr advises you that the treatment is not suitable for you  there is no charge.

As with any kind of medication, Wegovy can cause side effects in some patients.

Common side effects of Wegovy include:

    Nausea,   Diarrhoea,  Vomiting, Constipation,   lower stomach pain, headache, tiredness, upset stomach, dizziness
    feeling bloated,belching and gas,Heartburn , some of these can be controlled with changes to your diet

Wegovy is not suitable for patients with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2)



company logo
call Albany Medical Centre  on the following contact details:
Sidcup on 020 8300 9900 
Newport on 01633 243 533 
Pontypridd on 01443 400 391
London Bridge on 0207 403 3922